ARCHIVES

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Feral Mouse Colony Recompetition Given Concept Approval

November 16, 1990

In Brief: Grants Compromise Still In Doubt As Natcher, Conte Hold Out for 6,500; House Marks Up Bill

July 12, 1985

Study Suggests Biomarker For Resistance to Tamoxifen

March 25, 2011

Funding Opportunities.

April 19, 2002

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

December 15, 2000

Funding Opportunities Listed.

January 21, 2005